Inhibitory effect of Cd2+ on glycine-induced chloride current in rat hippocampal neurons

2006 ◽  
Vol 69 (6) ◽  
pp. 680-686 ◽  
Author(s):  
Shu Wang ◽  
Yan Gu ◽  
Hui-Li Wang ◽  
Xin-Mei Li ◽  
Ming Wang ◽  
...  
2021 ◽  
Author(s):  
Weiping Tao ◽  
Xuesong Zhang ◽  
Juan Ding ◽  
Shijian Yu ◽  
Peiqing Ge ◽  
...  

Abstract Background: BDNF/TrkB pathway dysregulation may be induced by hypoxia and inflammation, and play pivotal roles during the development of neurological disorders. Propofol is an anesthetic agent with neuro-protective properties. We aimed to verify whether propofol affected BDNF/TrkB pathway in neurons exposed to hypoxia or TNF-α.Methods: Primary rat hippocampal neurons and astrocytes were cultured and exposed to propofol followed by hypoxia or TNF-α treatment. The production of BDNF and the expression/truncation/phosphorylation of TrkB were measured. The underlying mechanisms such as ERK, CREB, p35 and Cdk5 were investigated.Results: In hippocampal neurons and astrocytes, hypoxia and TNF-α reduced the production of BDNF. Pretreatment of hippocampal neurons with 25μM propofol reversed the inhibitory effect of hypoxia or TNF-α on BDNF production. However, even 100μM propofol had no such effect in astrocytes. Further, we found that in hippocampal neurons hypoxia and TNF-α increased the phosphorylaion of ERK (p-ERK) and CREB at Ser142 (p-CREBSer142), while reduced the phosphorylation of CREB at Ser133 (p-CREBSer133), which were all reversed by 25μM propofol and 10μM ERK inhibitor. In addition, neither hypoxia nor TNF-α affected TrkB expression, truncation or phosphorylation in hippocampal neurons and astrocytes. However 50μM propofol induced TrkB phosphorylation without affecting its expression and truncation only in hippocampal neurons. Furthermore, we detected that in hippocampal neurons, 50μM propofol induced p35 expression and Cdk5 activation, and blockade of p35 or Cdk5 mitigated propofol-induced TrkB phosphorylation.Conclusions: Propofol, via ERK/CREB and p35/Cdk5, may modulate BDNF/TrkB pathway in hippocampal neurons that were exposed to hypoxia or TNF-α.


2020 ◽  
Vol 170 (11) ◽  
pp. 613-617
Author(s):  
J. V. Bukanova ◽  
◽  
E. I. Solntseva ◽  
R. V. Kondratenko ◽  
V. G. Skrebitsky ◽  
...  

2002 ◽  
Vol 296 (2) ◽  
pp. 247-254 ◽  
Author(s):  
Sunoh Kim ◽  
Kwangseog Ahn ◽  
Tae Hwan Oh ◽  
Seung-Yeol Nah ◽  
Hyewhon Rhim

2004 ◽  
Vol 279 (44) ◽  
pp. 46271-46279 ◽  
Author(s):  
Jui-ling Chou ◽  
Chuen-Lin Huang ◽  
Hsing-Lin Lai ◽  
Amos C. Hung ◽  
Chen-Li Chien ◽  
...  

In the present study, we used the N terminus (amino acids 1∼160) of type VI adenylyl cyclase (ACVI) as bait to screen a mouse brain cDNA library and identified Snapin as a novel ACVI-interacting molecule. Snapin is a binding protein of SNAP25, a component of the SNARE complex. Co-immunoprecipitation analyses confirmed the interaction between Snapin and full-length ACVI. Mutational analysis revealed that the interaction domains of ACVI and Snapin were located within amino acids 1∼86 of ACVI and 33–51 of Snapin, respectively. Co-localization of ACVI and Snapin was observed in primary hippocampal neurons. Moreover, expression of Snapin specifically eliminated protein kinase C (PKC)-mediated suppression of ACVI, but not that of cAMP-dependent protein kinase (PKA) or calcium. Mutation of the potential PKC and PKA phosphorylation sites of Snapin did not affect the ability of Snapin to reverse the PKC inhibitory effect on ACVI. Phosphorylation of Snapin by PKC or PKA therefore might not be crucial for Snapin action on ACVI. In contrast, SnapinΔ33–51, which harbors an internal deletion of amino acids 33–51 did not affect PKC-mediated inhibition of ACVI, supporting that amino acids 33–51 of Snapin comprises the ACVI-interacting region. Consistently, Snapin exerted no effect on PKC-mediated inhibition of an ACVI mutant (ACVI-ΔA87), which lacked the Snapin-interacting region (amino acids 1–86). Snapin thus reverses its action via direct interaction with the N terminus of ACVI. Collectively, we demonstrate herein that in addition to its association with the SNARE complex, Snapin also functions as a regulator of an important cAMP synthesis enzyme in the brain.


2020 ◽  
Vol 26 ◽  
Author(s):  
Qiang Gao ◽  
Xiaocheng Guo ◽  
Yang Cao ◽  
Xiaotong Jia ◽  
Shanshan Xu ◽  
...  

Background: The aging of hippocampal neurons leads to a substantial decline in memory formation, storage and processing. The neuroprotective effect of melatonin has been confirmed, however its protective mechanism remains unclear. Objective: In this study, mouse hippocampus-derived neuronal HT22 cells were used to investigate whether melatonin protects the hippocampus from hydrogen peroxide (H2O2)-induced injury by regulating autophagy. Methods: Rapamycin (an activator of autophagy) and 3-methyladenine (3MA, an inhibitor of autophagy) were used to induce or inhibit autophagy, respectively. HT22 cells were treated with 200 μM H2O2 in the presence or absence of 50 μM melatonin. Cell counting kit 8 (CCK-8), β-galactosidase and Hoechst staining were used to measure the viability, aging and apoptosis of cells, respectively. Western blot analysis was used to detect the levels of autophagy-related proteins. Results: The activation of autophagy by rapamycin alleviated H2O2-induced oxidative injury, as evidenced by morphological changes and decreased viability, while the inhibition of autophagy by 3MA exacerbated H2O2-induced injury. The inhibitory effect of melatonin on H2O2-induced injury was similar to that of rapamycin. Melatonin also alleviated H2O2-induced aging and apoptosis. Melatonin activated autophagy in the presence or absence of H2O2, as evidenced by an increased Lc3b 14/16 kd ratio and a decreased P62 level. In addition, H2O2 decreased the levels of Beclin1 and Atg5/12/16, which were reversed by rapamycin or melatonin. The effects of melatonin on H2O2-induced injury, autophagy and protein expressions were effectively reversed by 3MA. Conclusion: In conclusion, these results demonstrate that melatonin protects HT22 hippocampal neurons from H2O2- induced injury by increasing the levels of the Beclin1 and Atg proteins to activate autophagy.


1995 ◽  
Vol 74 (1) ◽  
pp. 464-469 ◽  
Author(s):  
A. M. Costa ◽  
K. T. Spence ◽  
S. S. Smith ◽  
J. M. ffrench-Mullen

1. The withdrawal properties of the endogenous steroid progesterone (P) were tested in female rats as a function of benzodiazepine modulation of gamma-aminobutyric acid-A (GABAA)-gated current with the use of the whole cell patch-clamp technique on acutely dissociated CA1 hippocampal neurons. In a previous study, this steroid was shown to exhibit withdrawal properties, behaviorally. 2. One day withdrawal from in vivo administration of physiological doses of P (5 mg ip, 5 days/wk for 3 withdrawal cycles) or its metabolite, the GABAA modulator 3 alpha-hydroxy-5 alpha-pregnan-20-one (3 alpha,5 alpha-THP or allopregnanolone, 20 mg/kg ip) prevented the normally potentiating effect of lorazepam (LZM; 10(-7)-10(-4) M) on GABAA-gated current. Withdrawal from 500 micrograms P administered concomitantly with 2 micrograms 17 beta-estradiol also markedly diminished LZM potentiation of GABAA current. This effect was seen only after three withdrawal cycles. 3. P withdrawal produced no inhibitory effect on either basal levels of GABAA-evoked current, the GABAA EC50, or barbiturate (+/-Pentobarbital, 10(-7)-10(-4) M) modulation of this parameter. 4. The effect of steroid withdrawal on LZM modulation of GABAA-evoked current was blocked by picrotoxin as well as by indomethacin, a drug that prevents conversion of P to its metabolite, the GABAA modulator 3 alpha,5 alpha-THP. These results suggest that the withdrawal properties of P may be due to changes in GABAA receptor function produced by 3 alpha,5 alpha-THP.


2021 ◽  
Vol 170 (5) ◽  
pp. 649-653
Author(s):  
J. V. Bukanova ◽  
E. I. Solntseva ◽  
R. V. Kondratenko ◽  
V. G. Skrebitsky

Sign in / Sign up

Export Citation Format

Share Document